News
Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted approval of darolutamide in combination with androgen deprivation therapy ...
Paris, France (21 July 2025) – EssilorLuxottica announces today it has signed an agreement with the South Korean company PUcore for the acquisition of all its assets and entities involved in the ...
Les activités acquises par EssilorLuxottica comprennent une unité de R&D, un site de production de matériaux et une équipe commerciale, basés en République de Corée. Dans le cadre de cette transaction ...
Dr. Xie Fangmin remarked, “We are partnering with Novo Nordisk, a leading global healthcare company, to explore AI technology ...
Bonatech, a company specialising in the application of membrane technology for the research and development of membrane materials and the manufacturing of membrane equipment, has announced the ...
Take D-Bal, for instance. Inspired by Dianabol, it uses a blend of MSM, Ashwagandha, L-Leucine, and Suma Root to increase ...
Workout Routine For Men Revealed: How To Build Muscle Fast With CrazyBulk Muscle Gaining Supplements
For men seeking a fast-track to lean muscle growth and fat reduction, the Growth Hormone Stack by CrazyBulk is gaining ...
Déployer plus largement la vaccination contre l’infection à VRS (virus respiratoire syncytial), dont l’impact, depuis son ...
Accèdez sans limite aux 15 000 actualités du site et recevez gratuitement chaque semaine, la Newsletter Santé log avec les ...
The APOE4 gene affects 25% of the population and drives 44% of all Alzheimer's cases, creating a $181 billion annual burden in the U.S. alone. With 1.1 billion carriers worldwide facing dramatically ...
HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer and serious infectious diseases, ...
The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback